5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: A retrospective analysis of pooled, prospective phase 2 trials
    Journal Article

    Sonpavde, G.; Pond, G. R.; Fougeray, R.; Choueiri, T. K.; Qu, A. Q.; Vaughn, D. J.; Niegisch, G.; Albers, P.; James, N. D.; Wong, Y. N.; more...
    European Urology (2013)

    Fulltext@MSK | Save
  • Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation
    Journal Article

    Morris, L. G. T.; Kaufman, A. M.; Gong, Y.; Ramaswami, D.; Walsh, L. A.; Turcan, S.; Eng, S.; Kannan, K.; Zou, Y.; Peng, L.; more...
    Nature Genetics (2013)

    Fulltext@MSK | Save
  • Sunitinib Does Not Accelerate Tumor Growth in Patients with Metastatic Renal Cell Carcinoma
    Journal Article

    Blagoev, K.; Wilkerson, J.; Stein, W. D.; Motzer, R. J.; Bates, S. E.; Fojo, A. T.
    Cell Reports (2013)

    Fulltext@MSK | Save
  • Specific PPAR gamma agonists may have different effects on cancer incidence
    Journal Article

    Bambury, R. M.; Iyer, G.; Rosenberg, J. E.
    Annals of Oncology (2013)

    Fulltext@MSK | Save
  • Repurposing itraconazole as a treatment for advanced prostate cancer: A noncomparative randomized phase ii trial in men with metastatic castration-resistant prostate cancer
    Journal Article

    Antonarakis, E. S.; Heath, E. I.; Smith, D. C.; Rathkopf, D.; Blackford, A. L.; Danila, D. C.; King, S.; Frost, A.; Seun Ajiboye, A.; Zhao, M.; more...
    The Oncologist (2013)

    Fulltext@MSK | Save
  • β4 Integrin signaling induces expansion of prostate tumor progenitors
    Journal Article

    Yoshioka, T.; Otero, J.; Chen, Y.; Kim, Y. M.; Koutcher, J. A.; Satagopan, J.; Reuter, V.; Carver, B.; de Stanchina, E.; Enomoto, K.; more...
    Journal of Clinical Investigation (2013)

    Fulltext@MSK | Save
  • Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: A single institution experience
    Journal Article

    Voss, M. H.; Lunning, M. A.; Maragulia, J. C.; Papadopoulos, E. B.; Goldberg, J.; Zelenetz, A. D.; Horwitz, S. M.
    Clinical Lymphoma, Myeloma and Leukemia (2013)

    Fulltext@MSK | Save
  • Oncogenic activation of Pak1-dependent pathway of macropinocytosis determines BCG entry into bladder cancer cells
    Journal Article

    Redelman-Sidi, G.; Iyer, G.; Solit, D. B.; Glickman, M. S.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Androgen receptor antagonists in castration-resistant prostate cancer
    Journal Article

    Rathkopf, D.; Scher, H. I.
    The Cancer Journal (2013)

    Fulltext@MSK | Save
  • BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer
    Journal Article

    Grisham, R. N.; Iyer, G.; Garg, K.; DeLair, D.; Hyman, D. M.; Zhou, Q.; Iasonos, A.; Berger, M. F.; Dao, F.; Spriggs, D. R.; more...
    Cancer (2013)

    Fulltext@MSK | Save